Omar Ishrak is a global healthcare and technology thought leader, with a passion for using technology to innovate, invent, and disrupt healthcare. He is recognized as a creative and forward-thinking problem solver. He speaks often on the global stage about the intersection of healthcare and technology, and the importance of innovation in transforming healthcare to deliver value for all stakeholders. 
 
Omar is Chairman of the Board at Intel. Intel (Nasdaq: INTC) is an industry leader, creating world-changing technology that enables global progress and enriches lives. Inspired by Moore’s Law, Intel works to advance the design and manufacturing of semiconductors to help address customer challenges by embedding intelligence in the cloud, network, edge and every kind of computing device, Intel harnesses the potential of data to transform business and society for the better.
 
As Chairman and CEO of Medtronic, Omar redefined the company’s growth strategy, driven by the purpose outlined in its enduring Mission — to use technology to improve human welfare. He rejuvenated the company’s technology pipeline, strengthened its position in emerging markets, and advanced efforts in value-based healthcare.
 
Prior to joining Medtronic, Omar was President and CEO of GE Healthcare Systems. He also held leadership positions at Diasonics/Vingmed, and various product development and engineering positions at Philips Ultrasound.
 
He grew up in Bangladesh and earned a Bachelor of Science degree and Ph.D. in Electrical Engineering from the University of London, King’s College. He is a Fellow of King’s College. He was inducted to the American Institute for Medical and Biological Engineering (AIMBE) College of Fellows in 2016 and was elected to the National Academy of Engineering in 2020.
 
Omar serves on the Board of Directors of Cleveland Clinic, Cargill, Amgen, and Insightec, and as Chairman of the Board of Directors of Biofourmis. He serves on the Board of Trustees of the Asia Society and is a Senior Advisor to Blackstone Life Sciences.